Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Unresolving MODS
NCT00127985Phase 4Unknown
- Sponsor
- Hospital Universitario Príncipe de Asturias
- Start
- Aug 2005
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in multiple organ dysfunction syndrome (MODS) comparing Methylprednisolone with Placebo (2 arms). Primary endpoints: All cause ICU and 28-day mortality and Organ dysfunction score at Day 28. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
multiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on NCT00127985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127985.